LDL-Apheresis removes serum amyloid P and A in hypercholesterolemic patients.
Palumbo
B
B
Department of Nuclear Medicine, University of Vienna, and Institute for Diagnosis and Treatment of Lipid Disorders and Atherosclerosis (ATHOS), Vienna, Austria.
Cardinali
L
L
Sinzinger
H
H
D000328:Adult; D001781:Blood Component Removal / Q000379:methods*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000628:therapy*; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D000685:Serum Amyloid A Protein / Q000302:isolation & purification / Q000378:metabolism*; D000683:Serum Amyloid P-Component / Q000302:isolation & purification / Q000378:metabolism*; D016896:Treatment Outcome
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008077:Lipoproteins, LDL; D000685:Serum Amyloid A Protein; D000683:Serum Amyloid P-Component; D002784:Cholesterol